Literature DB >> 10214661

Chromatographic analysis of bisphosphonates.

R W Sparidans1, J den Hartigh.   

Abstract

Chromatographic analysis of bisphosphonates in the past has been based primarily on reversed-phase liquid chromatography (RPLC) and ion-exchange chromatography. Gas chromatography (GC) and recently even capillary electrophoresis have also been employed. For bioanalysis, pre-treatment of the sample is a major part of the analysis; protein precipitation, calcium precipitation, solid-phase extraction (SPE) and derivatization have demonstrated to play an important role in bisphosphonate assays. For some of these treatments, for example SPE and derivatization, automation may be possible. Derivatization is a prerequisite for GC analysis of bisphosphonates; a volatile derivative has to be formed. For liquid chromatography, two types of derivatization are known for bisphosphonates. First, the bisphosphonate side chain can be modified by a chemical reaction to yield a derivative with advantageous chromatographic and spectroscopic properties. Secondly, by complexation of both phosphonate groups or of phosphate after decomposition of the analyte, a coloured complex can be formed. The most sensitive bioanalytical methods are based on RPLC and fluorescence detection, if necessary after derivatization. If low detection limits are not required, for example for analysis of pharmaceutical preparations, non-specific detection methods can be applied.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10214661     DOI: 10.1023/a:1008646810555

Source DB:  PubMed          Journal:  Pharm World Sci        ISSN: 0928-1231


  32 in total

1.  Determination of a new bisphosphonate, YM175, in plasma, urine and bone by high-performance liquid chromatography with electrochemical detection.

Authors:  T Usui; T Watanabe; S Higuchi
Journal:  J Chromatogr       Date:  1992-12-23

2.  Semi-automatic liquid chromatographic analysis of pamidronate in serum and citrate plasma after derivatization with 1-naphthylisothiocyanate.

Authors:  R W Sparidans; J den Hartigh; J H Beijnen; P Vermeij
Journal:  J Chromatogr B Biomed Sci Appl       Date:  1998-02-13

3.  The binding of pyrophosphate and two diphosphonates by hydroxyapatite crystals.

Authors:  A Jung; S Bisaz; H Fleisch
Journal:  Calcif Tissue Res       Date:  1973-03-30

4.  Determination of 4-amino-1-hydroxybutane-1,1-bisphosphonic acid in urine by automated pre-column derivatization with 2,3-naphthalene dicarboxyaldehyde and high-performance liquid chromatography with fluorescence detection.

Authors:  W F Kline; B K Matuszewski; W F Bayne
Journal:  J Chromatogr       Date:  1990-12-14

5.  Analysis of (dichloromethylene) bisphosphonate in urine by capillary gas chromatography-mass spectrometry.

Authors:  S Auriola; R Kostiainen; M Ylinen; J Mönkkönen; P Ylitalo
Journal:  J Pharm Biomed Anal       Date:  1989       Impact factor: 3.935

6.  Quantitative determination of ethane-1-hydroxy-1,1-diphosphonate in urine and plasma.

Authors:  S Bisaz; R Felix; H Fleisch
Journal:  Clin Chim Acta       Date:  1975-12-15       Impact factor: 3.786

7.  High-performance liquid chromatographic method for simultaneous determination of clodronate and some clodronate esters.

Authors:  V Virtanen; L H Lajunen
Journal:  J Chromatogr       Date:  1993-08-11

8.  The determination of 4-amino-1-hydroxybutane-1,1-diphosphonic acid monosodium salt trihydrate in pharmaceutical dosage forms by high-performance liquid chromatography.

Authors:  J D De Marco; S E Biffar; D G Reed; M A Brooks
Journal:  J Pharm Biomed Anal       Date:  1989       Impact factor: 3.935

9.  Assay of 1-hydroxy-3-aminopropylidene-1,1-bisphosphonate and related bisphosphonates in human urine and plasma by high-performance ion chromatography.

Authors:  P T Daley-Yates; L A Gifford; C R Hoggarth
Journal:  J Chromatogr       Date:  1989-05-30

10.  Determination of (4-chlorophenyl)thiomethylene bisphosphonic acid, a new bisphosphonate, in biological fluids by high-performance liquid chromatography.

Authors:  J P Fels; J Guyonnet; Y Berger; W Cautreels
Journal:  J Chromatogr       Date:  1988-08-19
View more
  5 in total

1.  Bone-Seeking Matrix Metalloproteinase-2 Inhibitors Prevent Bone Metastatic Breast Cancer Growth.

Authors:  Marilena Tauro; Gemma Shay; Samer S Sansil; Antonio Laghezza; Paolo Tortorella; Anthony M Neuger; Hatem Soliman; Conor C Lynch
Journal:  Mol Cancer Ther       Date:  2017-01-09       Impact factor: 6.261

2.  Metal complexation chemistry used for phosphate and nucleotide determination: an investigation of the Yb3+-pyrocatechol violet sensor.

Authors:  Ernestas Gaidamauskas; Kanokkarn Saejueng; Alvin A Holder; Subalita Bharuah; Boris A Kashemirov; Debbie C Crans; Charles E McKenna
Journal:  J Biol Inorg Chem       Date:  2008-08-14       Impact factor: 3.358

3.  Complexation of bisphosphonates with ytterbium(III): application of phosphate and ATP detection assay based on Yb(3+)-pyrocatechol violet.

Authors:  Ernestas Gaidamauskas; Helen Parker; Boris A Kashemirov; Alvin A Holder; Kanokkarn Saejueng; Charles E McKenna; Debbie C Crans
Journal:  J Inorg Biochem       Date:  2009-09-20       Impact factor: 4.155

Review 4.  Pharmacokinetics/pharmacodynamics of bisphosphonates: use for optimisation of intermittent therapy for osteoporosis.

Authors:  Serge C L M Cremers; Goonaseelan Pillai; Socrates E Papapoulos
Journal:  Clin Pharmacokinet       Date:  2005       Impact factor: 5.577

5.  Pharmacokinetics of coadministration of levothyroxine sodium and alendronate sodium new effervescent formulation.

Authors:  H G Bone; M A Walter; M E Hurley; S Epstein
Journal:  Osteoporos Int       Date:  2017-02-16       Impact factor: 4.507

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.